Detalhe da pesquisa
1.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
2.
Cost-effectiveness of treating all hepatitis B-positive individuals in the United States.
J Viral Hepat
; 30(9): 718-726, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260095
3.
Cost-effectiveness and economic investment to eliminate chronic hepatitis C in Mexico.
J Viral Hepat
; 30(6): 551-558, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890700
4.
Hepatitis C prevalence and elimination planning in Pakistan, a bottom-up approach accounting for provincial variation.
J Viral Hepat
; 30(4): 345-354, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650932
5.
Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost-effectiveness model.
Liver Int
; 43(7): 1417-1426, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073160
6.
Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP).
Liver Int
; 43(4): 773-784, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606729
7.
Securing wider EU commitment to the elimination of hepatitis C virus.
Liver Int
; 43(2): 276-291, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196744
8.
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
J Hepatol
; 76(4): 771-780, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895743
9.
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.
Lancet
; 397(10272): 398-408, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516338
10.
Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies.
Clin Gastroenterol Hepatol
; 20(8): 1687-1700.e4, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474162
11.
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany.
J Viral Hepat
; 29(7): 536-542, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357770
12.
The Payer License Agreement, or "Netflix model," for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition.
Liver Int
; 42(7): 1503-1516, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289467
13.
HCV disease burden and population segments in Switzerland.
Liver Int
; 42(2): 330-339, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839578
14.
Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
Liver Int
; 42(9): 1930-1934, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894047
15.
Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach.
BMC Infect Dis
; 22(1): 397, 2022 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459120
16.
Impact of COVID-19 on global HCV elimination efforts.
J Hepatol
; 74(1): 31-36, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777322
17.
Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19.
Liver Int
; 41(9): 2024-2031, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051065
18.
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.
Liver Int
; 41(3): 456-463, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389788
19.
Global timing of hepatitis C virus elimination in high-income countries.
Liver Int
; 40(3): 522-529, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815353
20.
Optimization of hepatitis C virus screening strategies by birth cohort in Italy.
Liver Int
; 40(7): 1545-1555, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078234